Glycanostics
About
Glycanostics is developing early-stage tests for detection of 11 types of cancer. The tests are based on detection of glycan changes in blood in ELISA format. Our solution represents unique approach, protected by 6 patents so far.
What is your business/industry sector?
Biotech, Pharma and Cosmetics